Ehud Neumann, Yang-Sung Sohn, Alfredo E. Cardenas, Taylor Hays, Itai Alfoni, Assaf Friedler, Lauren J. Webb, Ron Elber, Rachel Nechushtai
{"title":"Molecular Mechanisms of the Cytotoxicity of an Anti-Cancer Peptide","authors":"Ehud Neumann, Yang-Sung Sohn, Alfredo E. Cardenas, Taylor Hays, Itai Alfoni, Assaf Friedler, Lauren J. Webb, Ron Elber, Rachel Nechushtai","doi":"10.1021/acs.jpcb.6c05478","DOIUrl":null,"url":null,"abstract":"<p>The molecular mechanisms of anticancer peptides (ACPs)\r\nare largely\r\nunknown, which makes their rational design challenging. Here, we investigate\r\nthe action of an ACP, the peptide NAF-1<sup>44–67</sup>, to\r\nelucidate a detailed reaction sequence with cancer cells. NAF-1<sup>44–67</sup> is a 24-amino-acid ACP derived from the human\r\ntransmembrane protein NAF-1, which resides in mitochondria and the\r\nER. We investigate the specificity, targeting, and induction of cancer\r\ncell death by the peptide using imaging experiments, trypsin assays,\r\nand atomistic-level computer simulations. We investigate peptide interactions\r\nwith and permeation into cancer cells, as well as large (LUVs) and\r\ngiant unilamellar vesicles (GUVs). The experiments and simulations\r\nare conducted on the native peptide and several point mutations. We\r\ndemonstrate a mechanism with the following sequential steps: 1. The\r\nACPs cross the plasma membrane of cancer cells efficiently without\r\ndamaging it. 2. Different ACPs target alternate organelles in the\r\ncancer cell. The native peptide and two-point mutations (F1W and Q23W)\r\ntarget the mitochondria. Another point mutation (L11W) targets the\r\nnucleus. 3. The ACPs initiate apoptosis by damaging the mitochondria.\r\nThey perturb the mitochondrial membrane and a membrane-embedded protein,\r\nNAF-1. We illustrated the critical role of the interaction of the\r\npeptide with the protein NAF-1 by examining cells that underexpress\r\nor overexpress NAF-1. Overexpressing NAF-1 enhances peptide cytotoxicity,\r\nwhile underexpressing the protein reduces it. The revealed molecular\r\nmechanism opens the way for further investigations into ACPs that\r\ntarget different cancer cells and inner organelles and induce apoptosis\r\nthrough multiple pathways.</p>","PeriodicalId":60,"journal":{"name":"The Journal of Physical Chemistry B","volume":"130 43","pages":"11407–11424"},"PeriodicalIF":3.2000,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Physical Chemistry B","FirstCategoryId":"1","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jpcb.6c05478","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The molecular mechanisms of anticancer peptides (ACPs)
are largely
unknown, which makes their rational design challenging. Here, we investigate
the action of an ACP, the peptide NAF-144–67, to
elucidate a detailed reaction sequence with cancer cells. NAF-144–67 is a 24-amino-acid ACP derived from the human
transmembrane protein NAF-1, which resides in mitochondria and the
ER. We investigate the specificity, targeting, and induction of cancer
cell death by the peptide using imaging experiments, trypsin assays,
and atomistic-level computer simulations. We investigate peptide interactions
with and permeation into cancer cells, as well as large (LUVs) and
giant unilamellar vesicles (GUVs). The experiments and simulations
are conducted on the native peptide and several point mutations. We
demonstrate a mechanism with the following sequential steps: 1. The
ACPs cross the plasma membrane of cancer cells efficiently without
damaging it. 2. Different ACPs target alternate organelles in the
cancer cell. The native peptide and two-point mutations (F1W and Q23W)
target the mitochondria. Another point mutation (L11W) targets the
nucleus. 3. The ACPs initiate apoptosis by damaging the mitochondria.
They perturb the mitochondrial membrane and a membrane-embedded protein,
NAF-1. We illustrated the critical role of the interaction of the
peptide with the protein NAF-1 by examining cells that underexpress
or overexpress NAF-1. Overexpressing NAF-1 enhances peptide cytotoxicity,
while underexpressing the protein reduces it. The revealed molecular
mechanism opens the way for further investigations into ACPs that
target different cancer cells and inner organelles and induce apoptosis
through multiple pathways.
期刊介绍:
An essential criterion for acceptance of research articles in the journal is that they provide new physical insight. Please refer to the New Physical Insights virtual issue on what constitutes new physical insight. Manuscripts that are essentially reporting data or applications of data are, in general, not suitable for publication in JPC B.